trial · primary record
Zongertinib
Non-small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 400 |
| Primary completion | 2036-09-02 |
| Primary endpoint | Disease-free survival (DFS) by investigator's assessment |
| Registry ID | NCT07195695 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:07.440Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07195695
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zongertinib · approval
- Zongertinib · compound